Paper2247451
X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.
Swain AL and 6 others. Proc Natl Acad Sci U S A, 1990. Cited by 258 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Papers, record 2247451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2247451
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Protease Inhibitors | Major topic |
| Oligopeptides | Major topic |
| Protease Inhibitors | Major topic |
| Amino Acid Sequence | |
| Binding Sites | |
| Crystallography | |
| Drug Design | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Protein Conformation | |
| X-Ray Diffraction |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI27302 | NIAID NIH HHS | United States | U01AI027302 | PubMed and NIH | NIH RePORTER |
| N01-CO-74101 | NCI NIH HHS | United States | N01CO074101 | PubMed and NIH | NIH RePORTER |
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1688646 | Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. | Nature | 1990 | https://conductscience.org/library/papers/1688646 | PubMed |
| 2 | 2690072 | Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2690072 | PubMed |
| 3 | 2183354 | Rational design of peptide-based HIV proteinase inhibitors. | Science | 1990 | https://conductscience.org/library/papers/2183354 | PubMed |
| 4 | 2184237 | Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease. | J Med Chem | 1990 | https://conductscience.org/library/papers/2184237 | PubMed |
| 5 | 6750410 | Potent new inhibitors of human renin. | Nature | 1982 | https://conductscience.org/library/papers/6750410 | PubMed |
| 6 | 3841182 | Stereochemically restrained refinement of macromolecular structures. | Methods Enzymol | 1985 | https://conductscience.org/library/papers/3841182 | PubMed |
| 7 | 3511903 | Human renin: a new class of inhibitors. | Biochem Biophys Res Commun | 1986 | https://conductscience.org/library/papers/3511903 | PubMed |
| 8 | 3306411 | A structural model for the retroviral proteases. | Nature | 1987 | https://conductscience.org/library/papers/3306411 | PubMed |
| 9 | 3313384 | Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3313384 | PubMed |
| 10 | 3314991 | On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogues. | Biochemistry | 1987 | https://conductscience.org/library/papers/3314991 | PubMed |
| 11 | 2450209 | Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli. | J Virol | 1988 | https://conductscience.org/library/papers/2450209 | PubMed |
| 12 | 3293801 | Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease. | Cell | 1988 | https://conductscience.org/library/papers/3293801 | PubMed |
| 13 | 3045820 | Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3045820 | PubMed |
| 14 | 3052294 | Chemical synthesis of peptides and proteins. | Annu Rev Biochem | 1988 | https://conductscience.org/library/papers/3052294 | PubMed |
| 15 | 3056930 | Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3056930 | PubMed |
| 16 | 2536902 | Crystal structure of a retroviral protease proves relationship to aspartic protease family. | Nature | 1989 | https://conductscience.org/library/papers/2536902 | PubMed |
| 17 | 2645523 | Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. | Nature | 1989 | https://conductscience.org/library/papers/2645523 | PubMed |
| 18 | 2649094 | Peptide substrates and inhibitors of the HIV-1 protease. | Biochem Biophys Res Commun | 1989 | https://conductscience.org/library/papers/2649094 | PubMed |
| 19 | 3334166 | Renin inhibitors. | Pharm Res | 1987 | https://conductscience.org/library/papers/3334166 | PubMed |
| 20 | 2548279 | Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. | Science | 1989 | https://conductscience.org/library/papers/2548279 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 258 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42812813 | Cutting-edge developments in computer-aided anti-HIV drug design. | Front Immunol | 2026 | https://conductscience.org/library/papers/42812813 | PubMed |
| 41011245 | Small Molecule Protease Inhibitors as Model Peptidomimetics. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011245 | PubMed |
| 35190671 | Prediction and molecular field view of drug resistance in HIV-1 protease mutants. | Sci Rep | 2022 | https://conductscience.org/library/papers/35190671 | PubMed |
| 34258737 | Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34258737 | PubMed |
| 32079302 | Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32079302 | PubMed |
| 30867891 | Stapled Peptides Inhibitors: A New Window for Target Drug Discovery. | Comput Struct Biotechnol J | 2019 | https://conductscience.org/library/papers/30867891 | PubMed |
| 27646017 | Structural studies of the yeast DNA damage-inducible protein Ddi1 reveal domain architecture of this eukaryotic protein family. | Sci Rep | 2016 | https://conductscience.org/library/papers/27646017 | PubMed |
| 27437081 | Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group. | ACS Med Chem Lett | 2016 | https://conductscience.org/library/papers/27437081 | PubMed |
| 25671429 | Integrated analysis of residue coevolution and protein structures capture key protein sectors in HIV-1 proteins. | PLoS One | 2015 | https://conductscience.org/library/papers/25671429 | PubMed |
| 25341668 | Current perspectives on HIV-1 antiretroviral drug resistance. | Viruses | 2014 | https://conductscience.org/library/papers/25341668 | PubMed |
| 24526384 | Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation. | J Mol Model | 2014 | https://conductscience.org/library/papers/24526384 | PubMed |
| 22316150 | Identification of HIV inhibitors guided by free energy perturbation calculations. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22316150 | PubMed |
| 21850570 | Insights into the structural function of the complex of HIV-1 protease with TMC-126: molecular dynamics simulations and free-energy calculations. | J Mol Model | 2012 | https://conductscience.org/library/papers/21850570 | PubMed |
| 21053051 | Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes. | J Comput Aided Mol Des | 2011 | https://conductscience.org/library/papers/21053051 | PubMed |
| 20593466 | The early years of retroviral protease crystal structures. | Biopolymers | 2010 | https://conductscience.org/library/papers/20593466 | PubMed |
| 20565756 | Co-lethality studied as an asset against viral drug escape: the HIV protease case. | Biol Direct | 2010 | https://conductscience.org/library/papers/20565756 | PubMed |
| 20210782 | Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. | Curr HIV Res | 2010 | https://conductscience.org/library/papers/20210782 | PubMed |
| 18289701 | Molecular mechanisms of FIV infection. | Vet Immunol Immunopathol | 2008 | https://conductscience.org/library/papers/18289701 | PubMed |
| 18004760 | Evaluating the potency of HIV-1 protease drugs to combat resistance. | Proteins | 2008 | https://conductscience.org/library/papers/18004760 | PubMed |
| 17869270 | Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors. | J Mol Biol | 2007 | https://conductscience.org/library/papers/17869270 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| PDB | UNKNOWN |
Source PDB
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2247451
GET https://conductscience.org/api/papers/v1/2247451/references?page=2